方晶晶
About 方晶晶
方晶晶 is a CMC Manager at BeiGene in Shanghai, with extensive experience in technical report writing, IND filing, and funding applications. She has held various roles in drug product development and formulation across multiple companies, including WuXi Biologics and Evive Biotech.
Title
方晶晶 currently serves as a CMC Manager at BeiGene, located in 中国 上海市 黄浦区. In this role, 方晶晶 manages processes related to Chemistry, Manufacturing, and Controls (CMC) for late-stage combination product development.
Company
方晶晶 is employed at BeiGene, a global biotechnology company specializing in the development and commercialization of innovative therapies. The company is based in China's Shanghai and focuses on oncology solutions among other biologic products.
Previous Experience
Prior to joining BeiGene, 方晶晶 held multiple roles at leading biotech firms. At WuXi Biologics, 方晶晶 served as the Drug Product Development group leader II from 2019 to 2021, specializing in product development. From 2017 to 2019, 方晶晶 was the Formulation and Characterization Manager at Evive Biotech. Before that, 方晶晶 worked as a Formulation Development Sr. Scientist at 上海恒瑞医药有限公司 from 2014 to 2017, and earlier served as a Formulation, Downstream Process, and Analytics Development Scientist at Evive Biotech from 2012 to 2014.
Education and Expertise
方晶晶 earned a 硕士 in Biomedical Science and a 学士 in Biology from 华东师范大学, studying there from 2005 to 2011. 方晶晶's academic background contributes to deep proficiency in areas such as technical report writing, IND filing dossiers, funding applications, and molecular developability assessments.
Downstream Process Development and Product Characterization
With a robust foundation in both downstream process development and product characterization, 方晶晶 possesses expertise crucial for advancing pharmaceutical products through various development stages. This includes hands-on experience with over 15 projects, ranging from pre-IND to phase III clinical trials.